Fosinopril treatment of pregnant rats

developmental toxicity, fetal angiotensin-converting enzyme inhibition, and fetal angiotensin II receptor regulation

Kevin Grove, R. J. Mayo, C. S. Forsyth, A. A. Frank, R. C. Speth

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Pregnant women are advised against using angiotensin-converting enzyme (ACE) inhibitors due to reports of adverse effects on human fetuses. This study examined ACE binding and angiotensin II (Ang II) receptor binding in fetuses of rats treated with the ACE inhibitor fosinopril (16 mg/kg/day fosinopril, p.o. in 4 divided doses, from gestational day (gd) 13 to gd 18). Binding of the potent radiolabeled ACE inhibitor 125I-351A to ACE in the lung and aorta of gd 19 fetuses of fosinopril-treated dams was reduced by 56 and 44%, respectively, compared to fetuses from vehicle-treated dams, indicating that fosinopril or its active metabolite, fosinoprilat, crosses the placental barrier and inhibits fetal ACE. Fetal Ang II receptor binding of 125I-Sar1,Ile8 Ang II was not altered in most of the tissues examined, although reductions in binding in the adrenal of fetuses of fosinopril-treated dams approached statistical significance.

Original languageEnglish (US)
Pages (from-to)85-95
Number of pages11
JournalToxicology Letters
Volume80
Issue number1-3
DOIs
StatePublished - 1995
Externally publishedYes

Fingerprint

Fosinopril
Enzyme inhibition
Angiotensin Receptors
Peptidyl-Dipeptidase A
Toxicity
Rats
Fetus
Angiotensin-Converting Enzyme Inhibitors
Dams
Therapeutics
Metabolites
Angiotensin II
Aorta
Pregnant Women
Tissue
Lung

Keywords

  • Angiotensin receptors
  • Angiotensin-converting enzyme
  • Fetus
  • Fosinopril
  • Rats

ASJC Scopus subject areas

  • Toxicology

Cite this

Fosinopril treatment of pregnant rats : developmental toxicity, fetal angiotensin-converting enzyme inhibition, and fetal angiotensin II receptor regulation. / Grove, Kevin; Mayo, R. J.; Forsyth, C. S.; Frank, A. A.; Speth, R. C.

In: Toxicology Letters, Vol. 80, No. 1-3, 1995, p. 85-95.

Research output: Contribution to journalArticle

Grove, Kevin ; Mayo, R. J. ; Forsyth, C. S. ; Frank, A. A. ; Speth, R. C. / Fosinopril treatment of pregnant rats : developmental toxicity, fetal angiotensin-converting enzyme inhibition, and fetal angiotensin II receptor regulation. In: Toxicology Letters. 1995 ; Vol. 80, No. 1-3. pp. 85-95.
@article{84bdedad1ad9416b9c17975ad2aeb02d,
title = "Fosinopril treatment of pregnant rats: developmental toxicity, fetal angiotensin-converting enzyme inhibition, and fetal angiotensin II receptor regulation",
abstract = "Pregnant women are advised against using angiotensin-converting enzyme (ACE) inhibitors due to reports of adverse effects on human fetuses. This study examined ACE binding and angiotensin II (Ang II) receptor binding in fetuses of rats treated with the ACE inhibitor fosinopril (16 mg/kg/day fosinopril, p.o. in 4 divided doses, from gestational day (gd) 13 to gd 18). Binding of the potent radiolabeled ACE inhibitor 125I-351A to ACE in the lung and aorta of gd 19 fetuses of fosinopril-treated dams was reduced by 56 and 44{\%}, respectively, compared to fetuses from vehicle-treated dams, indicating that fosinopril or its active metabolite, fosinoprilat, crosses the placental barrier and inhibits fetal ACE. Fetal Ang II receptor binding of 125I-Sar1,Ile8 Ang II was not altered in most of the tissues examined, although reductions in binding in the adrenal of fetuses of fosinopril-treated dams approached statistical significance.",
keywords = "Angiotensin receptors, Angiotensin-converting enzyme, Fetus, Fosinopril, Rats",
author = "Kevin Grove and Mayo, {R. J.} and Forsyth, {C. S.} and Frank, {A. A.} and Speth, {R. C.}",
year = "1995",
doi = "10.1016/0378-4274(95)03346-M",
language = "English (US)",
volume = "80",
pages = "85--95",
journal = "Toxicology Letters",
issn = "0378-4274",
publisher = "Elsevier BV",
number = "1-3",

}

TY - JOUR

T1 - Fosinopril treatment of pregnant rats

T2 - developmental toxicity, fetal angiotensin-converting enzyme inhibition, and fetal angiotensin II receptor regulation

AU - Grove, Kevin

AU - Mayo, R. J.

AU - Forsyth, C. S.

AU - Frank, A. A.

AU - Speth, R. C.

PY - 1995

Y1 - 1995

N2 - Pregnant women are advised against using angiotensin-converting enzyme (ACE) inhibitors due to reports of adverse effects on human fetuses. This study examined ACE binding and angiotensin II (Ang II) receptor binding in fetuses of rats treated with the ACE inhibitor fosinopril (16 mg/kg/day fosinopril, p.o. in 4 divided doses, from gestational day (gd) 13 to gd 18). Binding of the potent radiolabeled ACE inhibitor 125I-351A to ACE in the lung and aorta of gd 19 fetuses of fosinopril-treated dams was reduced by 56 and 44%, respectively, compared to fetuses from vehicle-treated dams, indicating that fosinopril or its active metabolite, fosinoprilat, crosses the placental barrier and inhibits fetal ACE. Fetal Ang II receptor binding of 125I-Sar1,Ile8 Ang II was not altered in most of the tissues examined, although reductions in binding in the adrenal of fetuses of fosinopril-treated dams approached statistical significance.

AB - Pregnant women are advised against using angiotensin-converting enzyme (ACE) inhibitors due to reports of adverse effects on human fetuses. This study examined ACE binding and angiotensin II (Ang II) receptor binding in fetuses of rats treated with the ACE inhibitor fosinopril (16 mg/kg/day fosinopril, p.o. in 4 divided doses, from gestational day (gd) 13 to gd 18). Binding of the potent radiolabeled ACE inhibitor 125I-351A to ACE in the lung and aorta of gd 19 fetuses of fosinopril-treated dams was reduced by 56 and 44%, respectively, compared to fetuses from vehicle-treated dams, indicating that fosinopril or its active metabolite, fosinoprilat, crosses the placental barrier and inhibits fetal ACE. Fetal Ang II receptor binding of 125I-Sar1,Ile8 Ang II was not altered in most of the tissues examined, although reductions in binding in the adrenal of fetuses of fosinopril-treated dams approached statistical significance.

KW - Angiotensin receptors

KW - Angiotensin-converting enzyme

KW - Fetus

KW - Fosinopril

KW - Rats

UR - http://www.scopus.com/inward/record.url?scp=0028786796&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028786796&partnerID=8YFLogxK

U2 - 10.1016/0378-4274(95)03346-M

DO - 10.1016/0378-4274(95)03346-M

M3 - Article

VL - 80

SP - 85

EP - 95

JO - Toxicology Letters

JF - Toxicology Letters

SN - 0378-4274

IS - 1-3

ER -